Biosimilar Sponsors May Seek Interchangeability Before FDA Sets Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
As with its approval of the first biosimilar product, FDA may also set precedent by making its first interchangeability determination before issuing guidance.